Associate Principal Scientist - Surface Plasmon Resonance specialist



AstraZeneca is a major international healthcare business engaged in the 
research, development, manufacture and marketing of prescription 
pharmaceuticals and the supply of healthcare services. But we are more than one 
of the world's leading pharmaceutical companies. At AstraZeneca, we are proud 
to have a unique workplace culture that inspires innovation and collaboration. 
Here, employees are empowered to express diverse perspectives - and are made to 
feel valued, energized and rewarded for their ideas and creativity.



The arena

The Biophysics team in Mölndal is part of a larger DECS organisation (300+ 
people), which supports disease areas (iMeds) globally across the company. The 
common denominator for DECS is that skills and expertise are highly specialised 
or capital-demanding, and therefore are gathered in a centralised organisation. 
AstraZeneca is now significantly expanding its biophysics capability.



>From Mölndal, we collaborate with the CNS/Pain (Södertälje & Montreal), 
>Respiratory and Inflammation (Mölndal) and Cardiovascular (Mölndal and UK) 
>iMeds. Within these project collaborations, the Biophysics team is responsible 
>for identification and/or characterisation of hit compounds, by studying 
>ligand-protein interactions using a wide variety of biophysical techniques 
>(focus is on NMR, SPR, and ITC).



We have a strong history of matrix working, predominantly with protein 
engineering, crystallography and high-throughput screening (all within DECS) 
and synthetic and computational chemistry (located in the iMeds).



The role

The position will offer an opportunity for an innovative scientist, with 
high-end expertise in bio-optical techniques, to play an influential role in 
building up and shaping the biophysics capability within DECS. The expert 
knowledge in the area will be applied directly in drug discovery projects. For 
example, by developing biophysical assays used for fragment screening, or for 
HTS as orthogonal primary or secondary assays. While focus will be on hit 
generation projects, later stage applications such as residence time 
optimization, will also be important. Applications may either be in 
high-throughput studies (screening) or in more detailed analysis of a smaller 
number of ligands.



The role will include representing the biophysics capability toward an iMed 
portfolio, where opportunities need to be recognized for a broader range of 
label-free techniques, aiming to maximize the impact of our biophysics 
resource, in driving enhanced quality of the lead-generation process. The 
ability to influence the direction of the lead-generation strategy will be 
important.



Finally, from a scientific perspective, the role will include identifying and 
driving discipline improvements and innovations that advance lead discovery 
projects. This includes implementing new opportunities for existing bio-optical 
techniques within an HTS frame work.



Minimum requirements

·         PhD degree with focus on biophysics and/or enzymology

·         Strong theoretical and practical knowledge of the kinetics of ligand 
binding, and implications for drug design

·         5+ years post-PhD experience with surface plasmon resonance, 
preferably in industrial setting

·         Recognised expert in SPR area (within company, or internationally), 
with ability to define the strategic direction for the use of optical 
biosensors in lead generation projects

·         Strong track record in both SPR assay development, and method 
development

·         Demonstrated ability to drive SPR in drug discovery projects, 
contributing to understanding of mode of action of ligands



Beneficial experiences

·         Hands-on experience with optical waveguide grating techniques, 
including assay design

·         Experience with fragment screening and fragment exploitation using 
SPR and/or related methods

·         Good understanding of and experience of working with protein 3D 
structures

·         A working knowledge of High Throughput Screening methodologies and 
science

·         Experience with high-throughput data handling/analysis

·         Experience with biochemical assay development





More information

For more information about the position please contact: Fredrik Edfeldt (team 
leader) at +46 (0)31 7761604.




Department: Structure, Biophysics & Computational Science, DECS.


Location: Mölndal, Sweden.



We welcome your application no later than 31 January 2011. Interviews will be 
conducted in February.




--------------------------------------------------------------------------
Confidentiality Notice: This message is private and may contain confidential 
and proprietary information. If you have received this message in error, please 
notify us and remove it from your system and note that you must not copy, 
distribute or take any action in reliance on it. Any unauthorized use or 
disclosure of the contents of this message is not permitted and may be unlawful.
 

Reply via email to